Narrative Update • Aug 18
Have your own idea? Try our Stock Screener
German (DAX) Clinical Research and Equipment Industry Analysis
UpdatedAug 21, 2026
DataAggregated Company Financials
Companies6
- 7D5.0%
- 3M8.3%
- 1Y12.6%
- YTDn/a
Last week, the Clinical Research and Equipment industry hasn't moved much but SCHOTT Pharma KGaA is up 6.8% in that time. The past year has been better, since the industry has gained 6.3% in that time. As for the next few years, earnings are expected to grow by 24% per annum.
Industry Valuation and Performance
Has the German Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Aug 2026 | €20.5b | €7.6b | -€185,489,979.98 | 56.4x | -110.6x | 2.7x |
| Sun, 19 Jul 2026 | €19.9b | €7.6b | -€209,219,631.66 | 62.5x | -95x | 2.6x |
| Tue, 16 Jun 2026 | €18.6b | €7.5b | €134.4m | 37x | 138x | 2.5x |
| Thu, 14 May 2026 | €17.3b | €7.5b | €141.4m | 39.2x | 122.5x | 2.3x |
| Sat, 11 Apr 2026 | €16.8b | €7.6b | €224.1m | 25.3x | 74.8x | 2.2x |
| Mon, 09 Mar 2026 | €17.3b | €7.5b | €168.6m | 28.1x | 102.9x | 2.3x |
| Wed, 04 Feb 2026 | €19.8b | €7.5b | €143.5m | 37.2x | 138.1x | 2.6x |
| Fri, 02 Jan 2026 | €19.4b | €7.5b | €143.5m | 40.8x | 135x | 2.6x |
| Sun, 30 Nov 2025 | €20.3b | €7.5b | €143.9m | 39.3x | 140.9x | 2.7x |
| Tue, 28 Oct 2025 | €20.2b | €7.5b | €147.4m | 43.5x | 136.8x | 2.7x |
| Thu, 25 Sep 2025 | €18.5b | €7.4b | €157.8m | 22.8x | 117.2x | 2.5x |
| Sat, 23 Aug 2025 | €18.6b | €7.4b | €157.8m | 25.1x | 118x | 2.5x |
| Mon, 21 Jul 2025 | €19.7b | €7.4b | €99.5m | 26x | 198.2x | 2.7x |
| Wed, 18 Jun 2025 | €20.1b | €7.3b | €114.9m | 28.7x | 174.8x | 2.8x |
| Fri, 16 May 2025 | €21.6b | €7.3b | €114.9m | 27.3x | 187.9x | 3x |
| Sun, 13 Apr 2025 | €17.7b | €7.2b | €125.5m | 24.8x | 141x | 2.5x |
| Tue, 11 Mar 2025 | €21.6b | €7.1b | €156.5m | 28.2x | 138.3x | 3x |
| Thu, 06 Feb 2025 | €23.8b | €7.1b | €169.8m | 23.5x | 140.1x | 3.4x |
| Sat, 04 Jan 2025 | €20.8b | €7.1b | €169.8m | 24.5x | 122.2x | 2.9x |
| Mon, 02 Dec 2024 | €22.0b | €7.1b | €170.5m | 27.6x | 129.2x | 3.1x |
| Wed, 30 Oct 2024 | €24.1b | €7.1b | €171.2m | 32x | 140.7x | 3.4x |
| Fri, 27 Sep 2024 | €24.5b | €7.1b | €172.8m | 30.8x | 141.5x | 3.5x |
| Sun, 25 Aug 2024 | €23.8b | €7.0b | €157.1m | 34.2x | 151.6x | 3.4x |
| Tue, 23 Jul 2024 | €22.7b | €7.0b | €237.1m | 35.8x | 95.8x | 3.2x |
| Thu, 20 Jun 2024 | €21.7b | €7.0b | €333.3m | 28.5x | 65.2x | 3.1x |
| Sat, 18 May 2024 | €26.6b | €7.0b | €340.1m | 30x | 78.2x | 3.8x |
| Mon, 15 Apr 2024 | €32.1b | €7.1b | €385.4m | 36.3x | 83.3x | 4.5x |
| Wed, 13 Mar 2024 | €33.9b | €7.1b | €384.5m | 37.2x | 88.1x | 4.8x |
| Fri, 09 Feb 2024 | €32.5b | €7.3b | €516.3m | 37.5x | 62.9x | 4.4x |
| Sun, 07 Jan 2024 | €30.8b | €7.3b | €507.1m | 34.8x | 60.7x | 4.2x |
| Tue, 05 Dec 2023 | €28.5b | €7.3b | €507.1m | 31.4x | 56.2x | 3.9x |
| Thu, 02 Nov 2023 | €24.8b | €6.4b | €356.1m | 37.5x | 69.5x | 3.9x |
| Sat, 30 Sep 2023 | €26.8b | €6.6b | €498.1m | 38.3x | 53.8x | 4.1x |
| Mon, 28 Aug 2023 | €29.1b | €6.6b | €425.8m | 42.5x | 68.3x | 4.4x |
Price to Earnings Ratio
68.3x
Current Industry PE
- Investors are pessimistic on the German Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.2x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 5.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does German Clinical Research and Equipment compare with similar industries?
| DE Market | -0.83% | |
| Healthcare | 0.43% | |
| Life Sciences | 4.97% | |
| Clinical Research and Equipment | 4.97% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1SXP SCHOTT Pharma KGaA | €22.75 | 4.4% +€143.1m | -3.2% | PE25.2x | |
| GXI Gerresheimer | €27.22 | 1.2% +€11.1m | -39.8% | PS0.4x |